FMEA-guided transition from microSelectron to Flexitron for HDR brachytherapy
To utilize failure mode and effects analysis (FMEA) to effectively direct the transition from the Elekta microSelectron to the Flexitron high dose-rate afterloader system. (Source: Brachytherapy)
Source: Brachytherapy - February 16, 2020 Category: Cancer & Oncology Authors: Fan-Chi Frances Su, YuHuei Jessica Huang, Prema Rassiah, Bill J. Salter Source Type: research

Maximizing gynecologic brachytherapy experience during radiation oncology residency training
Brachytherapy plays an integral role in the management of gynecologic malignancies. The use of brachytherapy in combination with external beam radiation has been correlated with an improvement in both local control and survival in patients with advanced stage cancers of the cervix and endometrium (1 –4). The widespread adoption of image-guided adaptive brachytherapy over the past decade has allowed treatment techniques, including the use of various applicators and interstitial needles, to become increasingly more complex and individualized. (Source: Brachytherapy)
Source: Brachytherapy - February 16, 2020 Category: Cancer & Oncology Authors: Jill S. Remick, Sushil Beriwal Tags: Editorial Source Type: research

Dose planning variations related to delineation variations in MRI-guided brachytherapy for locally advanced cervical cancer
To examine the variability in prescribed dose due to contouring variations in intracavitary image-guided adaptive brachytherapy for cervical cancer. To identify correlations between dosimetric outcomes and delineation uncertainty metrics. (Source: Brachytherapy)
Source: Brachytherapy - February 14, 2020 Category: Cancer & Oncology Authors: Lauren Bell, Lois Holloway, Kjersti Bruheim, Primo ž Petrič, Christian Kirisits, Kari Tanderup, Richard Pötter, Shalini Vinod, Karen Lim, Elise Pogson, Peter Metcalfe, Taran Paulsen Hellebust Source Type: research

Influence of tumor shape and location in eye plaque brachytherapy dosimetry
A common treatment planning technique for eye plaque brachytherapy is to model the tumor as an ellipse. For posterior tumors near the optic disc and fovea, this approach may lead to overlap between tumor and the organ at risk (OAR). We hypothesized that a superior plan can be generated by modeling the actual tumor shape. (Source: Brachytherapy)
Source: Brachytherapy - February 12, 2020 Category: Cancer & Oncology Authors: Matthew T. Studenski, Nirav V. Patel, Arnold Markoe, J. William Harbour, Stuart E. Samuels Source Type: research

Upfront radiotherapy with brachytherapy for medically inoperable and unresectable patients with high-risk endometrial cancer
Comprehensive surgery with adjuvant therapy is standard of care for high-risk endometrial cancers, whereas upfront radiotherapy with brachytherapy is indicated for inoperable/unresectable patients, irrespective of risk. We evaluated outcomes for inoperable/unresectable patients with high-risk endometrial cancer (HREC: stage III and/or grade 3) and low-risk endometrial cancer (LREC: stage I/II and grade 1/2) treated with upfront radiotherapy. (Source: Brachytherapy)
Source: Brachytherapy - February 12, 2020 Category: Cancer & Oncology Authors: Bhavani S. Gannavarapu, Brian Hrycushko, Xun Jia, Kevin Albuquerque Source Type: research

Improving gynecologic brachytherapy patient experience by optimizing MRI, anesthesia, and scheduling to decrease the length of time tandem and ovoid applicators are in place
Brachytherapy requires multiple different steps and plays a critical role in treatment for gynecological cancer. In an effort to improve gynecologic patient experience, we investigated how different aspects of the procedure influence how long the patient has the brachytherapy applicator in place. (Source: Brachytherapy)
Source: Brachytherapy - January 21, 2020 Category: Cancer & Oncology Authors: Melissa Usoz, Rie von Eyben, Dylann K. Fujimoto, Elizabeth A. Kidd Source Type: research

A dosimetric evaluation of a single urethral constraint for high-dose-rate prostate brachytherapy
The American Brachytherapy Society (ABS) consensus guidelines for high-dose-rate (HDR) prostate brachytherapy suggest 11 different dose constraints for the urethra. The purpose of this study is to evaluate whether a single urethral constraint of D0.1  cm3  (Source: Brachytherapy)
Source: Brachytherapy - January 18, 2020 Category: Cancer & Oncology Authors: Diana J. Lu, Tiffany Phillips, John DeMarco, Howard M. Sandler, Mitchell Kamrava Source Type: research

Can intermediate-energy sources lead to elevated bone doses for prostate and head & neck high-dose-rate brachytherapy?
Several radionuclides with high (60Co, 75Se) and intermediate (169Yb, 153Gd) energies have been investigated as alternatives to 192Ir for high-dose-rate brachytherapy. The purpose of this study was to evaluate the impact of tissue heterogeneities for these five high- to intermediate-energy sources in prostate and head& neck brachytherapy. (Source: Brachytherapy)
Source: Brachytherapy - January 18, 2020 Category: Cancer & Oncology Authors: Gabriel Famulari, Joanne Alfieri, Marie Duclos, T é Vuong, Shirin A. Enger Source Type: research

Prolonged hormonal therapy and external beam radiation independently increase the risk of Persistent Hypogonadism in men treated with prostate brachytherapy
To identify variables that predict persistent hypogonadism and castration in patients with prostate cancer (PCa) treated with brachytherapy (BT). (Source: Brachytherapy)
Source: Brachytherapy - January 17, 2020 Category: Cancer & Oncology Authors: Kyrollis Attalla, Daniel Sagalovich, Kathryn E. Marqueen, John P. Sfakianos, Ashutosh K. Tewari, Ketan K. Badani, Richard G. Stock, Nelson N. Stone Source Type: research

High-dose-rate brachytherapy for localized penile cancer: Evolution of a  technique
We present the results of penile SCC treated with HDR brachytherapy either interstitially or via a surface mold. (Source: Brachytherapy)
Source: Brachytherapy - January 17, 2020 Category: Cancer & Oncology Authors: Marina Marb án Marban-Orejas, Juanita Crook, Mira Keyes, Rustom Dubash, Deidre Batchelar Source Type: research

American Brachytherapy Society working group report on the patterns of care and a literature review of reirradiation for gynecologic cancers
Recurrences of previously irradiated gynecological malignancies are uncommon. Standardized management of these cases is not well established. We aim to provide an in-depth literature review and present current practice patterns among an international group of experienced practitioners in the reirradiation setting of gynecologic cancers. (Source: Brachytherapy)
Source: Brachytherapy - January 13, 2020 Category: Cancer & Oncology Authors: Alina Sturdza, Akila N. Viswanathan, Beth Erickson, Catheryn Yashar, Andrew Bruggemman, Jonathan Feddock, Ann Klopp, Sushil Beriwal, David Gaffney, Kathy Han, Mitchell Kamrava Source Type: research

Implementation of peer-review quality rounds for gynecologic brachytherapy in a high-volume academic center
We report on a gynecologic BT peer-review method implemented at a high-volume academic center. (Source: Brachytherapy)
Source: Brachytherapy - January 13, 2020 Category: Cancer & Oncology Authors: Minh-Phuong Huynh-Le, Aaron B. Simon, David J. Hoopes, John P. Einck, Catheryn M. Yashar, Daniel Scanderbeg, Dominique Rash, Derek Brown, Loren K. Mell, Parag R. Sanghvi, Arno J. Mundt, Todd Pawlicki, Jyoti S. Mayadev Source Type: research

Editorial Board
(Source: Brachytherapy)
Source: Brachytherapy - January 1, 2020 Category: Cancer & Oncology Source Type: research

Masthead
(Source: Brachytherapy)
Source: Brachytherapy - January 1, 2020 Category: Cancer & Oncology Source Type: research

Table of Contents
(Source: Brachytherapy)
Source: Brachytherapy - January 1, 2020 Category: Cancer & Oncology Source Type: research

The impact of rectal/bladder filling and applicator positioning on in  vivo rectal dosimetry in vaginal cuff brachytherapy using an enhanced therapy setting
The impact of rectal filling and bladder volume on in  vivo rectal dosimetry (IVD) in vaginal cuff brachytherapy (VCBT) is unknown. The purpose of this study was to compare rectal doses from IVD with those calculated from treatment planning and to identify influencing factors. (Source: Brachytherapy)
Source: Brachytherapy - December 26, 2019 Category: Cancer & Oncology Authors: Pia Franziska Luise Bergau, Markus A. Schirmer, Andreas Leha, Martin Leu, G ünter Emons, Clemens F. Hess, Andrea Hille Source Type: research

Hyaluronic acid gel injection in rectovaginal septum reduced incidence of rectal bleeding in brachytherapy for gynecological malignancies
The purpose of this study was to report our initial clinical results of hyaluronic acid gel injection (HGI) in the rectovaginal septum (RVS) to reduce the incidence of rectal bleeding in vaginal brachytherapy for gynecologic malignancies. (Source: Brachytherapy)
Source: Brachytherapy - December 23, 2019 Category: Cancer & Oncology Authors: Naoya Murakami, Satoshi Nakamura, Tairo Kashihara, Tomoyasu Kato, Yoshihiro Shibata, Kana Takahashi, Koji Inaba, Kae Okuma, Hiroshi Igaki, Yuko Nakayama, Razvan Galalae, Jun Itami Source Type: research

Dosimetric comparison of the INTRABEAM and Axxent for intraoperative breast radiotherapy
Breast intraoperative radiotherapy with electronic brachytherapy (eBT) sources, such as the Zeiss INTRABEAM and the Xoft Axxent, are used to treat the lumpectomy cavity using a stationary or a stepped 50  kVp X-ray source, respectively. For three comparable applicator sizes with volume differences (Source: Brachytherapy)
Source: Brachytherapy - December 23, 2019 Category: Cancer & Oncology Authors: Mubin Y. Shaikh, Sean Tanny Source Type: research

Time-driven activity-based costing of adjuvant vaginal cuff brachytherapy for uterine cancer in an integrated brachytherapy suite
Adjuvant vaginal cuff brachytherapy is well tolerated and reduces the risk of local recurrence in endometrial cancer. However, there is provider variation in the number of radiation treatments, which ranges from three to six fractions. Using time-driven activity-based costing, we calculated the cost to deliver three vs six fractions to determine the value of each regimen at our brachytherapy suite with CT-on-rails. (Source: Brachytherapy)
Source: Brachytherapy - December 21, 2019 Category: Cancer & Oncology Authors: Lucy Su, Sunil W. Dutta, Jason C. Sanders, Trudy Wu, Bruce Libby, Kara D. Romano, Timothy N. Showalter Source Type: research

The 100 most cited articles in cervical cancer brachytherapy
This study aimed to identify the 100 most cited research articles on cervical cancer brachytherapy. (Source: Brachytherapy)
Source: Brachytherapy - December 19, 2019 Category: Cancer & Oncology Authors: Xiaodi Tang, Zhipeng Zhao, Hongfu Zhao, Zhuang Mao Source Type: research

Dose distribution of brachytherapy for locally advanced (stage IIB) cervical cancer
The aim of the study was to compare the dose distributions of combined intracavitary and interstitial (IC/IS) brachytherapy with 3-catheter IC brachytherapy in treating locally advanced (stage IIB) cervical cancer. (Source: Brachytherapy)
Source: Brachytherapy - December 16, 2019 Category: Cancer & Oncology Authors: Xia Lin, Jia Peng Wang, Zhong Shan Liu, Jie Guo, Yun Feng Li, Xiao Jun Ren, Ling Qiu, Chun Yu Wang, Si Wen Jiang, Xiao Jing Jia, Tie-jun Wang Tags: Gynecologic Oncology Source Type: research

Favorable preservation of erectile function after prostate brachytherapy for localized prostate cancer
We analyzed the rate of preserved potency after prostate brachytherapy (PB) with radioactive seeds and the impact of patient comorbidities on post-PB erectile dysfunction (ED). (Source: Brachytherapy)
Source: Brachytherapy - December 16, 2019 Category: Cancer & Oncology Authors: Am élie Bazinet, Kevin C. Zorn, Daniel Taussky, Guila Delouya, Daniel Liberman Source Type: research

Resident experience in brachytherapy: An analysis of Accreditation Council for Graduate Medical Education case logs for intracavitary and interstitial brachytherapy from 2007 to 2018
We sought to characterize temporal trends of radiation oncology resident –reported case experience with intracavitary brachytherapy (ICBT) and interstitial brachytherapy (ISBT). (Source: Brachytherapy)
Source: Brachytherapy - December 12, 2019 Category: Cancer & Oncology Authors: Ashwin Shinde, Richard Li, Arya Amini, Neha Vapiwala, Peter Orio, John A. Vargo, Catheryn Yashar, Yi-Jen Chen, Sushil Beriwal, Scott Glaser Source Type: research

Long-term effectiveness and safety of image-based, transperineal combined intracavitary and interstitial brachytherapy in treatment of locally advanced cervical cancer
The aim of the study was to evaluate the impact of image-based combined intracavitary-interstitial brachytherapy (IC-ISBT) using a transperineal template in locally advanced cervical cancer treatment. (Source: Brachytherapy)
Source: Brachytherapy - December 5, 2019 Category: Cancer & Oncology Authors: Richa Tiwari, Geeta S. Narayanan, Sowmya Narayanan, Parmasivam Suresh Kumar Source Type: research

Validation of the NCCN prostate cancer favorable- and unfavorable-intermediate risk groups among men treated with I-125 low  dose rate brachytherapy monotherapy
To validate the 2019 NCCN subgroups of favorable- and unfavorable-intermediate risk (IR) prostate cancer among patients treated with brachytherapy, who are underrepresented in the studies used to develop the 2019 NCCN classification. (Source: Brachytherapy)
Source: Brachytherapy - December 5, 2019 Category: Cancer & Oncology Authors: Martin C. Tom, Chandana.A. Reddy, Timothy D. Smile, Ryan X. Zhang, Jay P. Ciezki, Kevin L. Stephans, Omar Y. Mian, Eric A. Klein, Steven Campbell, James Ulchaker, Kenneth Angermeier, Rahul D. Tendulkar Source Type: research

MRI-assisted radiosurgery: A quality assurance nomogram for palladium-103 and iodine-125 prostate brachytherapy
We sought to develop an activity nomogram for magnetic resonance (MR) –planned permanent seed prostate brachytherapy to improve quality assurance through a secondary dosimetric check. (Source: Brachytherapy)
Source: Brachytherapy - December 4, 2019 Category: Cancer & Oncology Authors: Alexander N. Hanania, Rajat J. Kudchadker, Teresa L. Bruno, Chad Tang, Mitchell S. Anscher, Steven J. Frank Source Type: research

Analysis of dose-effect relationship between DVH parameters and clinical prognosis of definitive radio(chemo)therapy combined with intracavitary/interstitial brachytherapy in patients with locally advanced cervical cancer: A single-center retrospective study
The purpose of the study was to explore the dose-effect relationship between dose-volume histogram parameters and clinical prognosis of definitive radio(chemo)therapy followed by intracavitary/interstitial brachytherapy in locally advanced cervical cancer. (Source: Brachytherapy)
Source: Brachytherapy - November 29, 2019 Category: Cancer & Oncology Authors: Ning Zhang, Yuhuan Tang, Xin Guo, Zhuang Mao, Wei Yang, Guanghui Cheng Source Type: research

Dosimetric analysis of breast cancer tumor bed boost: An interstitial brachytherapy vs. external beam radiation therapy comparison for deeply seated tumors
To dosimetrically compare interstitial brachytherapy (MIBT) vs. EBRT (3DCRT and high-energy electron beams) for deep-seated tumor bed boosts (depth ≥4 cm) in early-stage breast cancer. (Source: Brachytherapy)
Source: Brachytherapy - November 28, 2019 Category: Cancer & Oncology Authors: Hodjatollah Shahbazian, Roksana Bakhshali, Azin Shamsi, Ali Bagheri Source Type: research

Establishing a simulation-based education program for radiation oncology learners in permanent seed implant brachytherapy: Building validation evidence
The purpose of this study was to establish a simulation-based education program for radiation oncology learners in permanent seed implant brachytherapy. The first step in formalizing any education program is a validation process that builds evidence-based verification that the learning environment is appropriate. (Source: Brachytherapy)
Source: Brachytherapy - November 28, 2019 Category: Cancer & Oncology Authors: Michael Roumeliotis, Sarah Quirk, Siraj Husain, Alexandra Guebert, Elizabeth Watt, Amy Frederick, Kevin Martell, Michelle Hilts, Juanita Crook, Deidre Batchelar, Irene Ma, Tyler Meyer Source Type: research

Developing an intraoperative 3T MRI-guided brachytherapy program within a diagnostic imaging suite: Methods, process workflow, and value-based analysis
We integrated a brachytherapy procedural workflow within an existing diagnostic 3.0-T (3T) MRI suite. This setup facilitates intraoperative MRI guidance for optimal applicator positioning, particularly for interstitial needle placements in gynecologic cases with extensive parametrial involvement. (Source: Brachytherapy)
Source: Brachytherapy - November 27, 2019 Category: Cancer & Oncology Authors: Matthew S. Ning, Aradhana M. Venkatesan, R. Jason Stafford, Thao P. Bui, Richard Carlson, Neil S. Bailard, Sastry Vedam, Rasheda Davis, Nicholas D. Olivieri, Alexis B. Guzman, James R. Incalcaterra, Florence A. McKelvey, Nikhil G. Thaker, Gaiane M. Rauch, Source Type: research

Accelerated partial breast irradiation in the elderly: 5-Year results of the single fraction elderly breast irradiation (SiFEBI) phase I/II trial
To evaluate the clinical outcomes of a very-accelerated partial breast irradiation (vAPBI) in the elderly based on a single fraction of multicatheter interstitial high-dose rate brachytherapy (MIB). Mature results with a median follow-up of 5  years. (Source: Brachytherapy)
Source: Brachytherapy - November 22, 2019 Category: Cancer & Oncology Authors: Jean-Michel Hannoun-L évi, Daniel Lam Cham Kee, Jocelyn Gal, Renaud Schiappa, Arthur Hannoun, Yves Fouche, Mathieu Gautier, Rabia Boulahssass, Marie-Eve Chand Source Type: research

Low-dose-rate iodine-125 seed air kerma strength measurement intercomparison
The purpose of this study was to investigate the rate of compliance of air kerma strength (AKS) measurements of iodine-125 (I-125) seeds with international recommendations by departments in Australia and determine the potential impact of noncompliance. (Source: Brachytherapy)
Source: Brachytherapy - November 19, 2019 Category: Cancer & Oncology Authors: Joel Poder, Ryan Smith, Annette Haworth Source Type: research

The narrow door of success
As this year's Henschke Award recipient, I am extremely proud that the discipline of prostate brachytherapy has been studied carefully in a scientific manner with the procedure evolving from good to better to best. However, I am concerned regarding the long-term viability of brachytherapy. All successful organizations experience ups and downs and whether one is in the operating room, the board room, or on the playing field, it is clear that wins and losses and successes and failures are measured by the slimmest of margins. (Source: Brachytherapy)
Source: Brachytherapy - November 15, 2019 Category: Cancer & Oncology Authors: Gregory S. Merrick Tags: Editorial Source Type: research

Transperineal mapping biopsy improves selection of brachytherapy boost for men with localized prostate cancer
To determine if transperineal mapping biopsy (TPMB) can improve the selection of brachytherapy alone (BT) or brachytherapy boost (BTB) in men with localized prostate cancer. (Source: Brachytherapy)
Source: Brachytherapy - November 3, 2019 Category: Cancer & Oncology Authors: Nelson N. Stone, Vassilios Skouteris, Panagiotis-Marios Metsinis Source Type: research

Changes of CD68, CD163, and PD-L1 tumor expression during high-dose-rate and pulsed-dose-rate brachytherapy for cervical cancer
The objective was to determine CD68, CD163, and PD-L1 expression in biopsies from patients with cervical cancer and to compare the effects of HDR vs. PDR brachytherapy on the expression of these proteins. (Source: Brachytherapy)
Source: Brachytherapy - November 3, 2019 Category: Cancer & Oncology Authors: Miguel A. Berenguer Frances, Isabel Linares-Galiana, Rut Ca ñas Cortés, Susanna Marín i Borrás, Cristina Gutiérrez Miguélez, Dina Najjari, Andrea Slocker, Cinta Bellobí, María Santacana, María Pané Foix, M. Henar Alonso, Arturo Navarro-Martin, S Source Type: research

Editorial Board
(Source: Brachytherapy)
Source: Brachytherapy - November 1, 2019 Category: Cancer & Oncology Source Type: research

Masthead
(Source: Brachytherapy)
Source: Brachytherapy - November 1, 2019 Category: Cancer & Oncology Source Type: research

Table of Contents
(Source: Brachytherapy)
Source: Brachytherapy - November 1, 2019 Category: Cancer & Oncology Source Type: research

Reviewers Listing 2019
(Source: Brachytherapy)
Source: Brachytherapy - November 1, 2019 Category: Cancer & Oncology Source Type: research

Efficacy and safety of CT-guided 125I seed implantation as a salvage treatment for locally recurrent head and neck soft tissue sarcoma after surgery and external beam radiotherapy: A 12-year study at a single institution
The objective of this study was to evaluate the efficacy and safety of CT-guided radioactive 125I seed implantation as a salvage treatment for locally recurrent head and neck soft tissue sarcoma (HNSTS) after surgery and external beam radiotherapy. (Source: Brachytherapy)
Source: Brachytherapy - October 22, 2019 Category: Cancer & Oncology Authors: Yi Chen, Yuliang Jiang, Zhe Ji, Ping Jiang, Fei Xu, Yibao Zhang, Fuxing Guo, Ran Peng, Xuemin Li, Haitao Sun, Runhong Lei, Jinghong Fan, Weiyan Li, Junjie Wang Source Type: research

The role of palliative interventional radiotherapy (brachytherapy) in esophageal cancer: An AIRO (Italian Association of Radiotherapy and Clinical Oncology) systematic review focused on dysphagia-free survival
The aim of this review was to examine efficacy of palliative interventional radiotherapy (IRT) in esophageal cancer compared with other treatment in terms of dysphagia-free survival (DyFS) and safety. (Source: Brachytherapy)
Source: Brachytherapy - October 18, 2019 Category: Cancer & Oncology Authors: Valentina Lancellotta, Francesco Cellini, Bruno Fionda, Vitaliana De Sanctis, Cristiana Vidali, Vincenzo Fusco, Fernando Barbera, Maria Antonietta Gambacorta, Renzo Corv ò, Stefano Maria Magrini, Luca Tagliaferri Tags: Review Article Source Type: research

Comparison of outcome endpoints in intermediate- and high-risk prostate cancer after combined-modality radiotherapy
To compare a standard radio-oncological and a surgical biochemical failure definition after combined-modality radiation therapy (CRT) in men with intermediate- and high-risk prostate cancer. (Source: Brachytherapy)
Source: Brachytherapy - October 16, 2019 Category: Cancer & Oncology Authors: Andreas Boehle, Katharina Katic, Inke R. K önig, Irina Robrahn-Nitschke, Bernd Brandenburg Source Type: research

Racial differences in the PSA bounce in predicting prostate cancer outcomes after brachytherapy: Evidence from the Department of Veterans Affairs
African American men have historically had poorer prostate cancer biochemical and survival outcomes than Caucasians. However, emerging data suggest nononcologic factors drive much of this disparity. Prior evidence has suggested an association between a transient prostate specific antigen (PSA) bounce and improved biochemical control. However, racial differences in this relationship have remained relatively unexplored. (Source: Brachytherapy)
Source: Brachytherapy - October 11, 2019 Category: Cancer & Oncology Authors: Alexander N. Slade, Bassam Dahman, Michael G. Chang Source Type: research

Vaginal cuff brachytherapy in the adjuvant setting for patients with high-risk early-stage cervical cancer
To evaluate local control and survival of high-risk patients with early-stage cervical cancer submitted or not to vaginal cuff brachytherapy in the postoperative setting. (Source: Brachytherapy)
Source: Brachytherapy - October 10, 2019 Category: Cancer & Oncology Authors: Geovanne Pedro Mauro, Rodolpho Truffa Kleine, Samantha Cabral Severino da Costa, Helo ísa A. Carvalho Source Type: research

Automated applicator digitization for high-dose-rate cervix brachytherapy using image thresholding and density-based clustering
The purpose of the study was to develop and evaluate an automated digitization algorithm for high-dose-rate cervix brachytherapy, with the goal of reducing the duration of treatment planning, staff resources, variability, and potential for human error. (Source: Brachytherapy)
Source: Brachytherapy - October 5, 2019 Category: Cancer & Oncology Authors: Christopher L. Deufel, Shulan Tian, Benjamin B. Yan, Birjoo D. Vaishnav, Michael G. Haddock, Ivy A. Petersen Tags: Case Report Source Type: research

Economic impact of decreasing the fraction number in vaginal cuff brachytherapy: A direct cost analysis
The purpose of this study was to analyze the direct economic impact of two vaginal cuff brachytherapy (VBT) schedules in postoperative endometrial carcinoma (PEC) with similar vaginal control and toxicity results. (Source: Brachytherapy)
Source: Brachytherapy - October 3, 2019 Category: Cancer & Oncology Authors: Yaowen Zhang, Angeles Rovirosa, Carlos Ascaso, Antonio Herreros, Aureli Torne, Yan Li, Albert Biete, Joan S ánchez Source Type: research

The role of seed implantation in patients with unresectable pancreatic carcinoma after relief of obstructive jaundice using ERCP
The purpose of the study was to investigate the role of iodine-125 seed implantation, guided by endoscopic ultrasound (EUS) and/or percutanous ultrasound, in patients with unresectable pancreatic carcinoma after relief of obstructive jaundice using endoscopic retrograde cholangiopancreatography (ERCP). (Source: Brachytherapy)
Source: Brachytherapy - September 26, 2019 Category: Cancer & Oncology Authors: Wen Li, Xiangdong Wang, Zikai Wang, Tiantian Zhang, Fengchun Cai, Ping Tang, Jiangyun Meng, Hong Du, Hongbin Wang, Mingyang Li, Shuling Li Source Type: research

The vaginal cylinder: Misunderstood, misused, or trivial? An in-depth dosimetric and multiinstitutional outcome investigation
The purpose of the study was to investigate the impact on dose distribution and radiobiological metrics of common high-dose-rate vaginal brachytherapy treatment parameters and to analyze multiinstitutional data for clinically significant impact on outcomes in early-stage endometrial cancer. (Source: Brachytherapy)
Source: Brachytherapy - September 23, 2019 Category: Cancer & Oncology Authors: Christopher L. Guy, Emma C. Fields, Bridget A. Quinn, Christine M. Fisher, Colton J. Ladbury, Kara D. Romano, Dorin Todor Source Type: research

Optimization of prostate brachytherapy techniques with polyethylene glycol –based hydrogel spacers: A systematic review
The objective of this overview was to critically evaluate the effect of polyethylene glycol (PEG)-based hydrogel spacers during prostate brachytherapy with regard to dosimetric and clinical benefits, as well as procedure-related toxicity. (Source: Brachytherapy)
Source: Brachytherapy - September 18, 2019 Category: Cancer & Oncology Authors: Mahdieh Afkhami Ardekani, Hamed Ghaffari Tags: Review Article Source Type: research

Comparative analysis between interstitial brachytherapy and stereotactic body irradiation for local ablation in liver malignancies
Interstitial high-dose-rate brachytherapy (BT) is an alternative treatment option to stereotactic body radiotherapy (SBRT) for the ablative treatment of liver malignancies. The aim of the present comparative planning study was to reveal the possibilities and limitations of both techniques with regard to dosimetric properties. (Source: Brachytherapy)
Source: Brachytherapy - September 12, 2019 Category: Cancer & Oncology Authors: Peter Hass, Konrad Mohnike, Siegfried Kropf, Thomas B. Brunner, Mathias Walke, Dirk Albers, Cordula Petersen, Robert Damm, Franziska Walter, Jens Ricke, Maciej Powerski, Stefanie Corradini Source Type: research